Dr. Fabio Iwamoto, MD
Claim this profileColumbia University Medical Center
Studies Glioblastoma
Studies Relapse
16 reported clinical trials
28 drugs studied
Area of expertise
1Glioblastoma
Stage IV
IDH negative
MET positive
2Relapse
Stage IV
Stage III
MET positive
Affiliated Hospitals
Clinical Trials Fabio Iwamoto, MD is currently running
Tirabrutinib
for Central Nervous System Lymphoma
This trial is testing tirabrutinib alone and with other cancer drugs in patients with PCNSL. It targets those who haven't responded to previous treatments or are newly diagnosed. Tirabrutinib works by blocking a protein that helps cancer cells grow. Tirabrutinib was approved for use in treating primary central nervous system lymphoma.
Recruiting1 award Phase 210 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Fabio Iwamoto, MD
Clinical Trial Related3 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Fabio Iwamoto, MD has experience with
- Temozolomide
- Nivolumab
- Pembrolizumab
- Placebo
- Triamcinolone Acetonide
- Clindamycin Phosphate
Breakdown of trials Fabio Iwamoto, MD has run
Glioblastoma
Relapse
Cerebral Gliomas
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fabio Iwamoto, MD specialize in?
Fabio Iwamoto, MD focuses on Glioblastoma and Relapse. In particular, much of their work with Glioblastoma has involved Stage IV patients, or patients who are IDH negative.
Is Fabio Iwamoto, MD currently recruiting for clinical trials?
Yes, Fabio Iwamoto, MD is currently recruiting for 6 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Fabio Iwamoto, MD has studied deeply?
Yes, Fabio Iwamoto, MD has studied treatments such as Temozolomide, Nivolumab, Pembrolizumab.
What is the best way to schedule an appointment with Fabio Iwamoto, MD?
Apply for one of the trials that Fabio Iwamoto, MD is conducting.
What is the office address of Fabio Iwamoto, MD?
The office of Fabio Iwamoto, MD is located at: Columbia University Medical Center, New York, New York 10032 United States. This is the address for their practice at the Columbia University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.